Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Launched by SINGAPORE CHUNG HWA MEDICAL INSTITUTION · Sep 28, 2022
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying how to better understand the different types of conditions related to diabetes and pre-diabetes using Traditional Chinese Medicine (TCM) techniques combined with modern technology. The goal is to improve how we identify and treat these conditions among patients in Singapore, which may help in preventing diabetes and tailoring treatments to meet the specific needs of the local population.
To participate, individuals aged 21 to 75 who have been diagnosed with type II diabetes, prediabetes, or who are healthy without any chronic conditions are eligible. Participants will undergo a thorough evaluation during a single visit, which includes health assessments and questionnaires about their lifestyle and diet. The trial is currently recruiting, and the findings may provide valuable insights into more effective treatment options for diabetes and prediabetes in Singapore.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 21-75 years old, inclusive;
- * Clinically diagnosed with one of the following:
- • 1. Type II Diabetes Mellitus with or without hypertension and dyslipidemia
- • 2. Prediabetes with or without hypertension and dyslipidemia
- • 3. Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia
- Exclusion Criteria:
- • Subjects diagnosed with Gestational Diabetes
- • Subjects who are pregnant or lactating
- • Subjects with chronic heart failure, history of carcinomas with treatment of chemotherapy/radiotherapy, psychological, or psychiatric disorders
- • Subjects with heart diseases and transplanted devices such as pacemakers;
- • Subjects with acute infections such as upper respiratory infections, acute gastroenteritis, or urinary tract infections;
- • Subjects unable to undergo evaluation with the pulse sphygmograph, tongue detection or complete the questionnaire;
- • Subjects with communication disorders
- • Subjects with gastroenterology diseases or are diagnosed with 'spleen and stomach deficiency' (脾胃虚弱)
- • Subjects undergoing TCM treatment for diabetes or pre-diabetes within 1 week
About Singapore Chung Hwa Medical Institution
Singapore Chung Hwa Medical Institution is a leading healthcare organization dedicated to advancing medical research and patient care through innovative clinical trials. With a commitment to improving health outcomes, the institution collaborates with a network of healthcare professionals and researchers to facilitate the development of new therapies and medical interventions. By prioritizing patient safety and ethical standards, Singapore Chung Hwa Medical Institution plays a pivotal role in the clinical research landscape, contributing to the advancement of medical knowledge and enhancing the quality of life for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials